Atossa Therapeutics, Inc. (ATOS)
NASDAQ: ATOS · IEX Real-Time Price · USD
1.260
-0.020 (-1.56%)
Jul 12, 2024, 2:21 PM EDT - Market open

Atossa Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year
Current20232022202120202019 2018 - 2010
Market Capitalization
163110672036814
Upgrade
Market Cap Growth
145.72%64.77%-66.97%197.98%374.28%148.91%
Upgrade
Enterprise Value
7722-4466282
Upgrade
PE Ratio
--3.66-2.48-9.83-3.04-0.83
Upgrade
PB Ratio
1.881.210.571.472.501.09
Upgrade
P/FCF Ratio
-12.10-5.26-3.22-12.29-5.87-1.57
Upgrade
P/OCF Ratio
-12.12-5.27-3.22-12.30-5.88-1.57
Upgrade
EV/EBITDA Ratio
-4.77-0.721.64-3.21-1.59-0.10
Upgrade
EV/EBIT Ratio
-4.76-0.721.63-3.21-1.59-0.10
Upgrade
EV/FCF Ratio
-7.59-1.042.12-4.01-2.45-0.19
Upgrade
Debt / Equity Ratio
----0.000.00
Upgrade
Debt / EBITDA Ratio
----0.000.00
Upgrade
Debt / FCF Ratio
----0.00-0.01
Upgrade
Quick Ratio
15.7816.9219.9443.662.539.59
Upgrade
Current Ratio
16.3417.6121.2345.182.7310.83
Upgrade
Return on Equity (ROE)
-31.30%-29.50%-21.30%-14.60%-158.60%-105.70%
Upgrade
Return on Assets (ROA)
-29.90%-28.50%-20.70%-14.40%-117.10%-97.50%
Upgrade
Return on Capital (ROIC)
-36.45%-34.47%-23.47%-14.86%-53.73%-130.73%
Upgrade
Earnings Yield
-18.45%-27.29%-40.29%-10.17%-32.84%-120.26%
Upgrade
FCF Yield
-11.58%-19.00%-31.06%-8.13%-17.03%-63.73%
Upgrade
Buyback Yield / Dilution
1.03%0.43%-8.27%-934.13%-33.09%-104.36%
Upgrade
Total Shareholder Return
1.03%0.43%-8.27%-934.13%-33.09%-104.36%
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).